BCRX

BioCryst Pharmaceuticals, Inc. $8.12 1M -23.3% 3M -4.5% YTD +8.3% as of 2026-09-11
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.0%
Next 1 week
+0.9%
Next 1 month
-0.8%
Seasonality
Weak window historically
Next 30 days (to Oct 14): -6.1% median, 19% of the last 31 years finished up.
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 1
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.19%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.62 -0.1% · Seasonal tilt -0.7%
$31M/day volume 49% volatility +1% 1-year -78% from ATH
52-week range · 41% of the way up · -28% from the high
$6.00$11.22

Congressional trades in BCRX Full tracker →

2 members · 4 buys / 1 sells · $5K–$75K disclosed · latest filing Sep 4, 2026.

BUY GC Gilbert Cisneros · traded Jul 10, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Nov 13, 2025 $1K–$15K
BUY JG Josh Gottheimer · traded Oct 16, 2023 $1K–$15K
SELL JG Josh Gottheimer · traded Sep 15, 2023 $1K–$15K
BUY JG Josh Gottheimer · traded Aug 11, 2022 $1K–$15K

Earnings Full history →

Next report 2026-11-02 (Monday, before open, in 49 days) · EPS est. 0.12.

1-day std dev
11.1%
Finished up
42%
Biggest pop
+23.5%
Biggest drop
-40.4%

Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.